First-In-Human Phase I Dose Escalation Study of a Humanized Anti-CD200 Antibody (Samalizumab) In Patients with Advanced Stage B Cell Chronic Lymphocytic Leukemia (B-CLL) or Multiple Myeloma (MM)
暂无分享,去创建一个
D. Mahadevan | C. Bedrosian | A. Kukreja | M. Lanasa | S. Faas | L. Heffner | Maria Whelden | Terrie L Ulery | L. Li